AirSculpt posted a GAAP net loss of USD 1.11 million for the quarter ended June 30, 2026, widening from a GAAP net loss of USD 0.59 million.
Revenue fell 3% to USD 42.9 million, driven by a 2% drop in same-center average selling price, partly offset by 1% same-center case growth.
GAAP operating results swung to an operating loss of USD 29,000 as total operating expenses rose to 100.1% of revenue from 98.2%.
Adjusted EBITDA (non-GAAP) declined to USD 4.94 million, cutting adjusted EBITDA margin by 1.8 percentage points to 11.5%.
Case volume dipped 0.5% to 3,376, while revenue per case slid 2.1% to USD 12,707; the prior-year period benefited from the London clinic, closed Dec. 31, 2025.
AIRS•
